By staff writers

July 16, 2014 -- Proton beam therapy technology developer Ion Beam Applications (IBA) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Compact Gantry Beam Line (CGBL).

The compact gantry will be featured on IBA's ProteusOne single-room proton therapy system, according to the vendor. In addition to selling two ProteusOne systems in Japan, IBA has sold systems to clients in Shreveport, LA; Nice, France; and Taiwan.

Copyright © 2014

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking